Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Oluwaseun Kukoyi"'
Autor:
Sabrina Trelles, Joseph J. Disa, Oluwaseun Kukoyi, Robin H. Unger, Danielle Novetsky Friedman, Gregory S. Phillips, James Mechalakos, Kathryn Beal, Leonard H. Wexler, Stephen W. Dusza, Christopher L. Tinkle, Mario E. Lacouture, Azael Freites-Martinez, Suzanne L. Wolden, Morgan E Freret
Publikováno v:
JAMA Dermatol
Importance: Persistent radiation-induced alopecia (pRIA) and its management have not been systematically described. Objective: To characterize pRIA in patients with primary central nervous system (CNS) tumors or head and neck sarcoma. Design, setting
Autor:
Stephen W. Dusza, Alina Markova, Oluwaseun Kukoyi, Miguel-Angel Perales, Mario E. Lacouture, Susan E. Prockop, Arifa Chowdhury, Doris M. Ponce, Alexander Pan
Publikováno v:
Blood. 138:3915-3915
Oral ruxolitinib has been successfully used for the treatment of acute and chronic graft-versus-host disease (cGvHD) and topical ruxolitinib has demonstrated efficacy in clinical trials for vitiligo, atopic dermatitis, and psoriasis. Background: Ther
Autor:
Lisa Caratelli, Kwami Ketosugbo, Tony McGuire, Oluwaseun Kukoyi, Thomas Brinkman, Toni Anne Lisante, Judith Nebus, Adegboyega Adenaike, Mario E. Lacouture, Sarah J. Noor, Neena K. Tierney
Publikováno v:
Journal of the American Academy of Dermatology. 85:AB166
Autor:
Milan J. Anadkat, Benjamin Kaffenberger, Beth N. McLellan, Oluwaseun Kukoyi, Samuel Barone, Jennifer N. Choi, Kara Capriotti, Mario E. Lacouture, Shari Goldfarb
Publikováno v:
Invest New Drugs
Purpose Cancer therapy-associated paronychia (CAP) is a frequent adverse event associated with cytotoxic and targeted therapies that may impact dosing of anticancer therapies and patient quality of life (QoL). There are currently no evidence-based ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1ccc061c398e588213893243564dcf6
https://europepmc.org/articles/PMC7484976/
https://europepmc.org/articles/PMC7484976/
Autor:
Paul B. Chapman, Vanessa A Reed, Alina Markova, Azael Freites-Martinez, Wen-Hung Chung, Stephen W. Dusza, Oluwaseun Kukoyi, Gabriella Fabbrocini, Mario E. Lacouture, Adriana T. Lopez, Maria Carmela Annunziata, Jennifer Wu, Michael A. Postow, Robert J. Motzer, Margaret K. Callahan, Naiyer A. Rizvi, Matthew D. Hellmann, Donald Chan, Gregory S. Phillips, Chih-Hsun Yang, Aliyah Pabani, Larisa J. Geskin, Jonathan E. Rosenberg
PURPOSE The aim of the current study was to report the efficacy of topical and systemic treatments for immune-related cutaneous adverse events (ircAEs) attributed to checkpoint inhibitors in an uncontrolled cohort of patients referred to oncodermatol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc490e4a496d732f394a4191bad7177
http://hdl.handle.net/11588/849803
http://hdl.handle.net/11588/849803
Autor:
Robin H. Unger, Sabrina Trelles, Joseph J. Disa, Gregory S. Phillips, Morgan E Freret, Danielle Novetsky Friedman, Mario E. Lacouture, Kathryn Beal, Suzanne L. Wolden, Azael David Freites Martinez, Leonard H. Wexler, Oluwaseun Kukoyi
Publikováno v:
Journal of Clinical Oncology. 37:e23072-e23072
e23072 Background: Persistent radiation-induced alopecia (pRIA), or incomplete hair regrowth 6 months following radiotherapy (RT) completion, poses a significant quality of life burden, but its clinical characteristics and management outcomes are not
Autor:
Azael Freites-Martinez, Oluwaseun Kukoyi, Mario E. Lacouture, Andrea Samuels, Shari Goldfarb, Sujata Patil, Jerry Shapiro, Kathryn Ciccolini
Publikováno v:
Journal of Clinical Oncology. 36:e12500-e12500
e12500Background: Late effects such as persistent alopecia, skin aging, and nail dystrophy resulting from cytotoxic or endocrine agents used in early stages of breast cancer are poorly understood. ...